Ronen Eckhouse

Ronen Eckhouse is the CEO and co-founder of Rapid Medical, a company focused on developing innovative neurovascular technologies for stroke treatment.14

Professional Background

Ronen Eckhouse has been instrumental in leading Rapid Medical since its inception. The company, which he co-founded in 2008, specializes in creating responsive and remotely adjustable interventional tools for treating ischemic and hemorrhagic strokes.14

Leadership and Expertise

As CEO, Eckhouse is part of a leadership team that combines decades of global MedTech experience to advance neurovascular technologies.1 His role involves guiding the company's strategic direction and promoting its innovative solutions in the medical field.

Recent Activities

Eckhouse has been actively representing Rapid Medical at various industry events:

1. In August 2024, he presented at the Future of Healthcare Investment Forum hosted by the London Stock Exchange.2
2. In July 2024, he spoke at BIOMED2024, emphasizing the company's commitment to expanding neurovascular therapy.3

Company Achievements

Under Eckhouse's leadership, Rapid Medical has made significant strides:

• The company has raised substantial funding, including a $50 million Series D round in 2021, bringing its total funding to $87 million at that time.4
• Rapid Medical has developed proprietary manufacturing techniques for creating innovative stroke treatment tools.1
• The company has established a global presence with its headquarters in Northern Israel.1

Ronen Eckhouse's work at Rapid Medical demonstrates his commitment to pioneering solutions in neurovascular therapy and improving patient outcomes in stroke treatment.